UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000048457
Receipt number R000055224
Scientific Title A multi center, phase 3 study to evaluate safety and efficacy of extensive intraoperative peritoneal lavage, that project to prevent recurrence, in the laparoscopic surgery for advanced colon cancer
Date of disclosure of the study information 2022/07/26
Last modified on 2022/07/25 22:04:31

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

A multi center, phase 3 study to evaluate safety and efficacy of extensive intraoperative peritoneal lavage, that project to prevent recurrence, in the laparoscopic surgery for advanced colon cancer

Acronym

SENJYO study

Scientific Title

A multi center, phase 3 study to evaluate safety and efficacy of extensive intraoperative peritoneal lavage, that project to prevent recurrence, in the laparoscopic surgery for advanced colon cancer

Scientific Title:Acronym

SENJYO study

Region

Japan


Condition

Condition

locally advanced colon cancer

Classification by specialty

Gastrointestinal surgery

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

To evaluate safety and efficacy of extensive intraoperative peritoneal lavage in the laparoscopic surgery for advanced colon cancer.

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Relapse free survival of pathological T4 and/or N2 cases

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Open -no one is blinded

Control

Active

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Maneuver

Interventions/Control_1

In the treatment group, surgeons perform EIPL (extensive intraoperative peritoneal lavage).

Interventions/Control_2

In the control group, surgeons perform peritonel lavage with less than 1L of saline.

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

1) Written consent to participate in the study has been obtained from the patient.
2) Performance Status (ECOG) of either 0 or 1.
3) Patient has operable general condition and organ function.
4) Patients with scheduled laparoscopic surgery for locally advanced colon cancer.

Key exclusion criteria

1) Patients with history of surgery within 4weeks
2) Patients with multiple cancers

Target sample size

2600


Research contact person

Name of lead principal investigator

1st name Mamoru
Middle name
Last name Uemura

Organization

Osaka University, Graduate School of Medicine

Division name

Departments of Gastroenterological surgery

Zip code

565-0871

Address

2-2 Yamadaoka, Suita, Osaka

TEL

06-6879-3251

Email

muemura@gesurg.med.osaka-u.ac.jp


Public contact

Name of contact person

1st name Yusuke
Middle name
Last name Takahashi

Organization

National Hospital Organization Osaka National Hospital

Division name

Department of Surgery

Zip code

540-0006

Address

2-1-14 Hoenzaka, Chuo-ku, Osaka

TEL

06-6942-1331

Homepage URL


Email

takahashi.yusuke.eu@mail.hosp.go.jp


Sponsor or person

Institute

Multicenter Clinical Study Group of Osaka, Colorectal Cancer Treatment Group

Institute

Department

Personal name



Funding Source

Organization

None

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Osaka University, Graduate School of Medicine

Address

2-2 Yamadaoka, Suita, Osaka

Tel

06-6210-8290

Email

jim-chiken@hp.crc.med.osaka-u.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2022 Year 07 Month 26 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Preinitiation

Date of protocol fixation

2022 Year 07 Month 25 Day

Date of IRB


Anticipated trial start date

2022 Year 08 Month 01 Day

Last follow-up date

2028 Year 08 Month 01 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2022 Year 07 Month 25 Day

Last modified on

2022 Year 07 Month 25 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000055224


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name